| Stereochemistry | ABSOLUTE |
| Molecular Formula | C20H18F6N2O5S |
| Molecular Weight | 512.423 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@@H](OC1=CC=C(C=C1C(=O)N2C[C@@H]3C[C@@]3(C2)C4=NOC(=C4)C(F)(F)F)S(C)(=O)=O)C(F)(F)F
InChI
InChIKey=MYHDQTVHHMSLEF-DDBGAENHSA-N
InChI=1S/C20H18F6N2O5S/c1-10(19(21,22)23)32-14-4-3-12(34(2,30)31)5-13(14)17(29)28-8-11-7-18(11,9-28)15-6-16(33-27-15)20(24,25)26/h3-6,10-11H,7-9H2,1-2H3/t10-,11+,18+/m1/s1
| Molecular Formula | C20H18F6N2O5S |
| Molecular Weight | 512.423 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
|
|
TARGET -> INHIBITOR |
In human SK-N-MC cells.
IC50
5 NANOMOLAR (average) |
Showing 1 to 1 of 1 entries
